Veracyte | VCYT - Trade Debtors

Stock Price
31.57
Daily Change
-1.10 -3.37%
Monthly
-3.69%
Yearly
4.36%
Q2 Forecast
31.28

Veracyte reported $44.66M in Trade Debtors for its fiscal quarter ending in December of 2025.





Trade Debtors Change Date
Agenus USD 22.44M 1.14M Dec/2025
Agilent USD 1.52B 34M Dec/2025
Anika Therapeutics USD 29.33M 661K Dec/2025
Arrowhead Research USD 218.87M 212.05M Dec/2025
Bruker USD 544.9M 6M Dec/2025
Heron Therapeutics USD 89.59M 8.54M Dec/2025
Illumina USD 854M 125M Dec/2025
Intrexon USD 1.02M 559K Jun/2024
Karyopharm Therapeutics USD 26.18M 5.6M Dec/2025
Laboratory Of America USD 2.26B 4.5M Dec/2025
Ligand Pharmaceuticals USD 58.1M 15.98M Sep/2025
Myriad Genetics USD 115.3M 2.7M Dec/2025
Rigel Pharmaceuticals USD 28.9M 1.39M Jun/2024
Roche Holding CHF 11.9B 460M Dec/2025
Sangamo BioSciences USD 581K 110K Jun/2024
Siemens EUR 26.81B 500M Dec/2025
Sonic Healthcare AUD 1.39B 23.76M Dec/2024
Thermo Fisher Scientific USD 8.9B 11M Dec/2025
Veracyte USD 44.66M 3.17M Dec/2025
Waters USD 828.84M 80.32M Dec/2025